Interferon-γ, but Not Interleukin-4, Suppresses Experimental Polymyositis.

Area of Science:

• Immunology
• Autoimmunity
• Muscle Inflammation

Background:

• C protein-induced myositis (CIM) is a CD8+ T cell-mediated autoimmune muscle disease.
• Previous models involving CD4+ T cells showed IFNγ disruption exacerbates disease via IL-17A.
• The role of IFNγ and IL-4 in CD8+ T cell-mediated CIM is not well understood.

Purpose of the Study:

• To investigate the roles of interferon-gamma (IFNγ), interleukin-4 (IL-4), and interleukin-17A (IL-17A) in CD8+ T cell-mediated CIM.
• To compare the effects of these cytokines in CD8+ T cell-driven CIM versus CD4+ T cell-driven autoimmune models.

Main Methods:

• Used knockout mice lacking IFNγ (IFNγ(-/-)), IL-17A (IL-17A(-/-)), or IL-4 (IL-4(-/-)), alongside wild-type mice.
• Induced CIM by immunizing mice with skeletal muscle C protein fragments.
• Examined muscle tissue histologically and assessed disease incidence and severity.

Main Results:

• IFNγ(-/-) mice exhibited higher incidence and severity of myositis with neutrophil infiltration compared to wild-type mice.
• Blocking IL-17A or deleting IL-17A in IFNγ(-/-) mice did not alter the exacerbated disease phenotype.
• IL-4(-/-) mice developed CIM with severity comparable to wild-type mice.

Conclusions:

• IFNγ plays a suppressive role in CD8+ T cell-mediated CIM, contrasting with its role in CD4+ T cell-driven autoimmunity.
• IFNγ prevents exacerbation of myositis and neutrophil infiltration through mechanisms independent of IL-17A in this CD8+ T cell model.